Zinc ascorbate

DB14485ApprovedNutraceuticalSmall molecule

Zinc ascorbate is a medication used to prevent the absorption of copper in Wilson's disease and also as part of natural health products.

Chemical structure of Zinc ascorbate
Formula / weight
C12H14O12Zn · 415.61 g/mol (avg)
First approval
Canada, 1987 · United States, 2015
Brand names
  • EnBrace HR
  • EnLyte

Resolves to

Compound
UNII9TI35313XWCAS331242-75-2
Clinical / RWD
RxNorm1549114ATCC05AX04
Structure
InChIKeyWWRJFSIRMWUMAE-ZZMNMWMASA-LSMILES[Zn++].[H][C@@]1(OC(=O)C(O)=C1[O-])[C@@H](O)CO.[H][C@@]1(OC(=O)C(O)=C1[O-])[C@@H](O)CO

What you can answer from here — as of April 02, 2025

127Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
6Marketed productsAcross 2 countries and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in

Which other approved drugs treat the same conditions as Zinc ascorbate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In